Discover and read the best of Twitter Threads about #JACC
Most recents (6)
ACC & @American_Heart released a 🆕report outlining key data elements & definitions for #ChestPain & acute myocardial infarction (#MI) based on the 2021 ACC/AHA Chest Pain Guideline. Take🏠Points in🧵Below ⬇️ #cvAMI #ClinicalGuidelines #JACC @JACCJournals
@American_Heart @JACCJournals 1⃣ The #ACCClinicalDoc presents a clinical lexicon of data elements related to #ChestPain & #cvAMI, in context of how the terms are used in the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR #ClinicalGuideline for the Evaluation and Diagnosis of Chest Pain: bit.ly/3CIBldf
2⃣ This lexicon follows the plans contained in the new #chestpain guideline and NOT all conceivable types and causes of chest pain are considered here. #ClinicalGuidelines @JACCJournals 
In patients with #HFpEF, treatment with #empagliflozin improves clinical outcomes regardless of background #MRA therapy
jacc.org/doi/10.1016/j.…
@JACCJournals #JACC @unic_cardiovasc @JavedButler1 @FaiezZANNAD #MiltonPacker @robmentz @BiykemB @HFpEF @ShelleyZieroth
jacc.org/doi/10.1016/j.…
@JACCJournals #JACC @unic_cardiovasc @JavedButler1 @FaiezZANNAD #MiltonPacker @robmentz @BiykemB @HFpEF @ShelleyZieroth
#MRAs were used in 37% of EMPEROR-Preserved study participants. MRA use was higher in those with a more congested clinical picture, with more HF🏥 within the past 12 months, worse HF symptoms, mildly reduced EF, higher NT-proBNP levels, and more use of loop diuretic agents
The effect of empagliflozin to reduce HF 🏥 was more pronounced in MRA nonusers than in MRA users, particularly in the subgroup of patients with LVEFs ≥50% @HFpEF @DrRyanPDaly @AndrewJSauer @AnastasiaSMihai @DrMarthaGulati @ErinMichos @ShelleyZieroth @mvaduganathan
1/16 Inspired by #NephMadness, let’s briefly touch on:
💢Role of kidney biomarkers in patients with CHF
💢‘Worsening kidney function’ in heart failure
💢Permissive hypercreatininemia
💢Handling RAASi and SGLT2i in heart failure
#NephTwitter #MedTwitter
ajkdblog.org/2022/03/01/nep…
💢Role of kidney biomarkers in patients with CHF
💢‘Worsening kidney function’ in heart failure
💢Permissive hypercreatininemia
💢Handling RAASi and SGLT2i in heart failure
#NephTwitter #MedTwitter
ajkdblog.org/2022/03/01/nep…
2/16 Let’s have a poll.
Forward failure, characterized by decreased kidney perfusion, is the main determinant of kidney dysfunction in acute decompensated heart failure. Is this true or false?
Forward failure, characterized by decreased kidney perfusion, is the main determinant of kidney dysfunction in acute decompensated heart failure. Is this true or false?
3/16 That’s false!
◀️“Backward failure” (Kidney congestion, interstitial edema and tubular dysfunction) is believed to play a more vital role compared to “Forward failure”▶️ (decreased kidney perfusion)
Neurohumoral and inflammatory mechanisms also operate
PMID:34970606
◀️“Backward failure” (Kidney congestion, interstitial edema and tubular dysfunction) is believed to play a more vital role compared to “Forward failure”▶️ (decreased kidney perfusion)
Neurohumoral and inflammatory mechanisms also operate
PMID:34970606
(1/12) #AFibAwareness #Tweetorial: Today the #ACCEP will be sharing information about #AFib risk factors, risk reduction techniques & more! Follow along as we discuss how mental health, exercise & OSA factor into AFib symptoms & treatment options. ⬇
@DrJCheungEP @Dr_Mike_Fradley (2/12) #AFibAwareness #Tweetorial: Normally, the human ❤ pumps >100k heartbeats each day. If you have #AFib, the ❤ doesn’t always beat the way it should.
People w/ AF are 5x more likely to have a #stroke, & it can lead to HF. Treating AF early can help: bit.ly/3eShyZl
People w/ AF are 5x more likely to have a #stroke, & it can lead to HF. Treating AF early can help: bit.ly/3eShyZl
(3/12) #AFibAwareness #Tweetorial: Some people with #AFib don’t have any symptoms. Those who do may report:
💗 Heart palpitations
😴 Feeling unusually tired
🌬️ Unexplained shortness of breath
😵 Dizziness
💥 Chest pain
bit.ly/3AAS0eV
💗 Heart palpitations
😴 Feeling unusually tired
🌬️ Unexplained shortness of breath
😵 Dizziness
💥 Chest pain
bit.ly/3AAS0eV
(1/12) #JACC #Tweetorial: #cvCAD in Young Adults: A Hard Lesson, but a Good Teacher
✔️#AFIJI Cohort 20 year-follow-up: fal.cn/34s2J @ActionCoeur
✔️ Editorial: fal.cn/34s2K by @ErinMichos and @AChoiHeart
✔️#AFIJI Cohort 20 year-follow-up: fal.cn/34s2J @ActionCoeur
✔️ Editorial: fal.cn/34s2K by @ErinMichos and @AChoiHeart
@ActionCoeur @ErinMichos @AChoiHeart @MichelZedBay @mathieukerneis @docjohanne @DrHulot_PARCC (2/12) #JACC #Tweetorial: The consequences of premature #cvCAD are devastating. Declines in ASCVD events have not extended to younger adults and rates have increased particularly among women 35-54 yrs old.
Arora, et al @CircAHA: fal.cn/34s2N
Arora, et al @CircAHA: fal.cn/34s2N
@ActionCoeur @ErinMichos @AChoiHeart @MichelZedBay @mathieukerneis @docjohanne @DrHulot_PARCC @CircAHA (3/12) #JACC #Tweetorial: In this issue Collet, JP, et al (@ActionCoeur) describe a cohort of 880 adults who experienced symptomatic #cvCAD at a young age (<45 years) presenting as obstructive CAD followed for up to 20 years. fal.cn/34s3H
(1/10) #JACC #Tweetorial: T2MI is #cvMI due to alterations in either myocardial oxygen supply and/or demand in the absence of acute atherothrombosis. It can occur in pts w/ normal coronaries and in obstructive/non-obstructive stable #cvCAD. fal.cn/AGvR
(2/10) #JACC #Tweetorial: Frequency of T2MI varies widely due to differences in populations, comorbidities, adjudication processes, & cTN assays, w/ a major challenge being the absence of uniform definitions that can be useful w/ high reproducibility. fal.cn/AGvR
(3/10) #JACC #Tweetorial: How T2MI manifests depends on the pathobiology & clinical context, w/ T2MIs less likely to have chest pain, imaging/#ECG abnormalities & ⬇ cardiac troponin concentrations compared to T1MI. Many T2MIs are driven by other illness. fal.cn/AGvR
